Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

ConclusionIn this large cohort, we confirm previous data about cladribine effectiveness on disease activity and disability worsening and provide information on response predictors that might inform therapeutic choices.

http://link.springer.com/10.1007/s40120-022-00364-6

Source: Neurology and Therapy - June 2, 2022 Category: Neurology Source Type: research